Waterstone Financial (NASDAQ:WSBF) reported quarterly earnings of $0.25 per share. This is a 68.35 percent decrease over earnings of $0.79 per share from the same period last year.
Sangamo Therapeutics Announces Preliminary Phase 1/2 Data Showing Tolerability, Sustained Elevated α-Gal A Enzyme Activity In Patients With Fabry Disease
Sangamo Therapeutics, Inc. (NASDAQ:SGMO), a genomic medicine company, today announced preliminary results from the Phase 1/2 STAAR clinical study evaluating isaralgagene civaparvovec, or ST-920, a wholly owned gene